{"companyId":272489,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"AbCellera Biologics Inc.","headOfficeLocation":"2215 Yukon Street, Vancouver, BC V5Y 0A1, Canada","presidentName":"Carl Hansen","companySummary":null,"stockCode":"ABCL","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["abcellera.com"],"businessContents":["Uses technology platforms to discover and develop antibody-based medicines."],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://abcellera.com/","scoreAbout":500,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}